Taken together, these data suggest the presence of a functional interaction between BRD4 and LOXL2, which may underlie future therapeutic interventions for cancer treatment, and which we therefore further investigated at the molecular, cellular, and tumor levels. Here, LOXL2 is linked to neoplasm.